Rules of Tumor Cell Development and Their Application to Biomarkers for Ovarian Cancer

2008 ◽  
Vol 35 (3) ◽  
pp. 403-409 ◽  
Author(s):  
Monica R. McLemore ◽  
Christine Miaskowski ◽  
Bradley E. Aouizerat ◽  
Lee-may Chen ◽  
Marylin Dodd
Keyword(s):  
Ovarian Cancer ◽  
Tumor Cell ◽  
Cell Development

M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

2021 ◽  
Author(s):  
Antonio Gil-Moreno ◽  
Lorena Alonso-Alconada ◽  
Berta Díaz-Feijoo ◽  
Santiago Domingo ◽  
Ana Vilar ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Tumor Cell ◽  
Cancer Patients ◽  
Advanced Ovarian Cancer ◽  
Metastatic Tumor ◽  
Metastatic Tumor Cell ◽  
And Performance

The long noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and ATG7 in hepatocellular carcinoma

2016 ◽  
Vol 12 (8) ◽  
pp. 2605-2612 ◽  
Author(s):  
Liang Yang ◽  
Xiuwei Zhang ◽  
Hangyu Li ◽  
Jingang Liu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Tumor Cell ◽  
Long Noncoding Rna ◽  
Antisense Rna ◽  
Noncoding Rna ◽  
Cell Development

The long noncoding RNA HOX transcript antisense RNA (HOTAIR) has been reported to be an oncogene that influences tumor cell development and that correlates with prognosis in hepatocellular carcinoma (HCC).

scholarly journals p53 and FBXW7: Sometimes Two Guardians Are Worse than One

Cancers ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 985
Author(s):  
María Galindo-Moreno ◽  
Servando Giráldez ◽  
M. Cristina Limón-Mortés ◽  
Alejandro Belmonte-Fernández ◽  
Carmen Sáez ◽  
...  
Keyword(s):  
Dna Damage ◽  
Tumor Suppressor ◽  
Tumor Cell ◽  
Cell Fate ◽  
Cell Development ◽  
Good Thing ◽  
Cancer Disease

Too much of a good thing can become a bad thing. An example is FBXW7, a well-known tumor suppressor that may also contribute to tumorigenesis. Here, we reflect on the results of three laboratories describing the role of FBXW7 in the degradation of p53 and the possible implications of this finding in tumor cell development. We also speculate about the function of FBXW7 as a key player in the cell fate after DNA damage and how this could be exploited in the treatment of cancer disease.

scholarly journals Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer

Medicine ◽  
2019 ◽  
Vol 98 (20) ◽  
pp. e15354 ◽  
Author(s):  
Miseon Kim ◽  
Dong Hoon Suh ◽  
Jin Young Choi ◽  
Jiyoon Bu ◽  
Yoon-Tae Kang ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Tumor Cell ◽  
Prognostic Marker ◽  
Circulating Tumor Cell ◽  
Advanced Stage

Circulating Tumor Cell-Free DNA Genes As Biomarkers For Platinum Resistant Ovarian Cancer Diagnosis

2020 ◽  
Vol 156 (3) ◽  
pp. e3-e4
Author(s):  
C.C. Gunderson ◽  
E.T. Evans ◽  
R. Radhakrishnan ◽  
R. Gomathinayagam ◽  
S. Husain ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Tumor Cell ◽  
Cancer Diagnosis ◽  
Circulating Tumor Cell ◽  
Cell Free Dna ◽  
Free Dna ◽  
Platinum Resistant

scholarly journals An Immunocompetent, Orthotopic Mouse Model of Epithelial Ovarian Cancer Utilizing Tissue Engineered Tumor Cell Sheets

2015 ◽  
Vol 21 (1) ◽  
pp. 23-34 ◽  
Author(s):  
Ayumi Arauchi ◽  
Chieh-Hsiang Yang ◽  
Sungpil Cho ◽  
Elke A. Jarboe ◽  
C. Matthew Peterson ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Mouse Model ◽  
Tumor Cell ◽  
Epithelial Ovarian Cancer ◽  
Cell Sheets ◽  
Orthotopic Mouse Model
Sign in / Sign up

Export Citation Format

Share Document